Is Eledon Pharmaceuticals, Inc. (ELDN) a Buy, Sell, or Hold?
NASDAQ : ELDN
Eledon Pharmaceuticals, Inc.
$3.86 USD
-$0.21 (-5.16%)
- Volume
- 764.7K
- Average Volume
- 1.45M
- Market Capitalization
- $231.4M
- P/E Ratio
- -4.44
- Dividend Yield
- 0.00%
- Price Target
- $5.00
- Year High
- $4.60
- Year Low
- $1.35
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $8.44
Institutional Ownership Summary
Institutional Ownership %
0.19%
Investors Holding
13
change: -110 | last: 123
Increased Positions
8
change: -70 | last: 78
Reduced Positions
0
change: -21 | last: 21
New Positions
5
change: -37 | last: 42
Sold Positions
115
change: 100 | last: 15
Total Calls
-
Total Puts
-
Put-Call Ratio
0.00
change: 0 | last: 0
Total Invested
858.57K
Beneficial Ownership Filings
| Filing Date | Reporting Person | Amount Beneficially Owned | % of Class |
|---|---|---|---|
| 2026-05-15 | BIOTECHNOLOGY VALUE FUND L P | 5.38M | 6.80% |
| 2026-04-27 | BlackRock, Inc. | 4.38M | 5.80% |
| 2026-03-26 | The Vanguard Group | - | 0.00% |
| 2026-02-17 | RA Capital Management, L.P. | - | 0.00% |
| 2026-02-13 | Coastlands Capital LP | 3.94M | 4.99% |
| 2026-01-21 | BlackRock, Inc. | 3.63M | 4.60% |
| 2025-11-24 | Coastlands Capital LP | 4.2M | 5.28% |
| 2025-07-29 | The Vanguard Group | 3.32M | 5.54% |
| 2025-07-17 | BlackRock, Inc. | 3.25M | 5.40% |
| 2025-02-14 | Armistice Capital, LLC | 3.14M | 4.99% |
| 2025-02-14 | Frazier Life Sciences Public Fund, L.P. | 878.08K | 1.50% |
| 2024-11-05 | FHMLSP, L.P. | 2.66M | 4.60% |
| 2024-11-05 | Frazier Life Sciences Public Fund, L.P. | 2.66M | 4.60% |
| 2024-11-05 | Frazier Life Sciences Public Fund, L.P. | 2.66M | 4.60% |
| 2024-11-05 | FHMLSP, L.P. | 2.66M | 4.60% |
| 2024-11-05 | Peter Kolchinsky | 3.57M | 6.10% |
| 2024-11-05 | RA Capital Healthcare Fund, L.P. | 3.57M | 6.10% |
| 2024-11-05 | Frazier Life Sciences X, L.P. | 39534.0 | 0.10% |
| 2024-11-05 | FHMLS XI, L.L.C. | 80493.0 | 0.10% |
| 2024-11-05 | FHMLS XI, L.L.C. | 80493.0 | 0.10% |
| 2024-11-05 | Patrick J. Heron | 3.56M | 6.10% |
| 2024-11-05 | Albert Cha | 3.44M | 5.90% |
| 2024-11-05 | James Brush | 3.44M | 5.90% |
| 2024-11-05 | Daniel Estes | 80493.0 | 0.10% |
| 2024-11-05 | James N. Topper | 3.56M | 6.10% |
| 2024-11-05 | FHMLSP, L.L.C. | 2.66M | 4.60% |
| 2024-11-05 | James Brush | 3.44M | 5.90% |
| 2024-11-05 | FHMLS X, L.P. | 39534.0 | 0.10% |
| 2024-11-05 | Frazier Life Sciences XI, L.P. | 80493.0 | 0.10% |
| 2024-11-05 | FHMLSP, L.L.C. | 2.66M | 4.60% |
| 2024-11-05 | Frazier Life Sciences Public Overage Fund, L.P. | 783.92K | 1.40% |
| 2024-11-05 | FHMLSP Overage, L.P. | 783.92K | 1.40% |
| 2024-11-05 | FHMLSP Overage, L.L.C. | 783.92K | 1.40% |
| 2024-11-05 | FHMLS X, L.P. | 39534.0 | 0.10% |
| 2024-11-05 | RA Capital Management, L.P. | 3.57M | 6.10% |
| 2024-11-05 | Peter Kolchinsky | 3.57M | 6.10% |
| 2024-11-05 | Rajeev Shah | 3.57M | 6.10% |
| 2024-11-05 | RA Capital Healthcare Fund, L.P. | 3.57M | 6.10% |
| 2024-11-05 | Rajeev Shah | 3.57M | 6.10% |
| 2024-11-05 | RA Capital Management, L.P. | 3.57M | 6.10% |
| 2024-11-05 | Daniel Estes | 80493.0 | 0.10% |
| 2024-11-05 | Patrick J. Heron | 3.56M | 6.10% |
| 2024-11-05 | James N. Topper | 3.56M | 6.10% |
| 2024-11-05 | Frazier Life Sciences XI, L.P. | 80493.0 | 0.10% |
| 2024-11-05 | FHMLS X, L.L.C. | 39534.0 | 0.10% |
| 2024-11-05 | FHMLS XI, L.P. | 80493.0 | 0.10% |
| 2024-11-05 | Albert Cha | 3.44M | 5.90% |
| 2024-11-05 | FHMLSP Overage, L.L.C. | 783.92K | 1.40% |
| 2024-11-05 | FHMLSP Overage, L.P. | 783.92K | 1.40% |
| 2024-11-05 | Frazier Life Sciences Public Overage Fund, L.P. | 783.92K | 1.40% |
| 2024-11-05 | Frazier Life Sciences X, L.P. | 39534.0 | 0.10% |
| 2024-11-05 | FHMLS X, L.L.C. | 39534.0 | 0.10% |
| 2024-11-05 | FHMLS XI, L.P. | 80493.0 | 0.10% |
| 2024-02-14 | Armistice Capital, LLC | 2.44M | 9.99% |
| 2024-02-14 | Steven Boyd | 2.44M | 9.99% |
| 2024-02-14 | Steven Boyd | 2.44M | 9.99% |
| 2024-02-14 | Armistice Capital, LLC | 2.44M | 9.99% |
| 2022-02-14 | Bihua Chen | 1.43M | 9.90% |
| 2022-02-14 | Cormorant Global Healthcare Master Fund, LP | 1.43M | 9.90% |
| 2022-02-14 | Cormorant Global Healthcare GP, LLC | 1.43M | 9.90% |
| 2022-02-14 | Cormorant Asset Management, LP | 1.43M | 9.90% |
| 2022-01-11 | Biotechnology Value Fund, L.P. | 791.34K | 5.50% |
| 2022-01-11 | BVF GP HOLDINGS LLC | 1.34M | 9.40% |
| 2022-01-11 | Mark N. Lampert | 1.43M | 9.99% |
| 2022-01-11 | BVF Inc. | 1.43M | 9.99% |
| 2022-01-11 | Biotechnology Value Fund, L.P. | 791.34K | 5.50% |
| 2022-01-11 | BVF I GP LLC | 791.34K | 5.50% |
| 2022-01-11 | Biotechnology Value Fund II, L.P. | 551.71K | 3.90% |
| 2022-01-11 | BVF II GP LLC | 551.71K | 3.90% |
| 2022-01-11 | Biotechnology Value Trading Fund OS LP | 71726.0 | 1.00% |
| 2022-01-11 | BVF Partners OS Ltd. | 71726.0 | 1.00% |
| 2022-01-11 | BVF Partners L.P. | 1.43M | 9.99% |
| 2021-02-16 | Woodline Partners LP | 814.76K | 5.40% |
| 2021-02-16 | Woodline Partners LP | 814.76K | 5.40% |
| 2021-02-08 | FMR LLC | 1M | 6.62% |
| 2021-02-08 | Select Biotechnology Portfolio | 1M | 6.62% |
| 2021-02-08 | FMR LLC | 1M | 6.62% |
| 2021-02-08 | Select Biotechnology Portfolio | 1M | 6.62% |
| 2021-02-08 | Abigail P. Johnson | 1M | 6.62% |
| 2021-02-08 | Abigail P. Johnson | 1M | 6.62% |
| 2021-01-05 | OrbiMed Israel BioFund GP Limited Partnership | 73650.0 | 0.50% |
| 2021-01-05 | OrbiMed Israel GP Ltd. | 73650.0 | 0.50% |
| 2021-01-04 | Bihua Chen | 1.42M | 9.89% |
| 2021-01-04 | Cormorant Global Healthcare Master Fund, LP | 1.42M | 9.89% |
| 2021-01-04 | Adage Capital Partners GP, L.L.C. | 892.56K | 5.89% |
| 2021-01-04 | Cormorant Asset Management, LP | 1.42M | 9.89% |
| 2021-01-04 | Adage Capital Partners, L.P. | 892.56K | 5.89% |
| 2021-01-04 | Adage Capital Advisors, L.L.C. | 892.56K | 5.89% |
| 2021-01-04 | Adage Capital Partners GP, L.L.C. | 892.56K | 5.89% |
| 2021-01-04 | Bihua Chen | 1.42M | 9.89% |
| 2021-01-04 | Cormorant Asset Management, LP | 1.42M | 9.89% |
| 2021-01-04 | Cormorant Global Healthcare GP, LLC | 1.42M | 9.89% |
| 2021-01-04 | Cormorant Global Healthcare Master Fund, LP | 1.42M | 9.89% |
| 2021-01-04 | Cormorant Global Healthcare GP, LLC | 1.42M | 9.89% |
| 2021-01-04 | Phillip Gross | 892.56K | 5.89% |
| 2021-01-04 | Adage Capital Partners, L.P. | 892.56K | 5.89% |
| 2021-01-04 | Robert Atchinson | 892.56K | 5.89% |
| 2021-01-04 | Phillip Gross | 892.56K | 5.89% |
| 2021-01-04 | Adage Capital Advisors, L.L.C. | 892.56K | 5.89% |
| 2021-01-04 | Robert Atchinson | 892.56K | 5.89% |
| 2020-11-20 | OrbiMed Israel BioFund GP Limited Partnership | 176.85K | 12.40% |
| 2020-11-20 | OrbiMed Israel GP Ltd. | 176.85K | 12.40% |
| 2020-11-09 | Logos Global Master Fund LP | 224.07K | 11.00% |
| 2020-11-09 | Logos Global Management GP LLC | 224.07K | 11.00% |
| 2020-11-09 | Logos GP LLC | 224.07K | 11.00% |
| 2020-11-09 | Logos GP LLC | 224.07K | 11.00% |
| 2020-11-09 | Logos Global Management LP | 224.07K | 11.00% |
| 2020-11-09 | Logos Global Management GP LLC | 224.07K | 11.00% |
| 2020-11-09 | Arsani William | 224.07K | 11.00% |
| 2020-11-09 | Logos Global Master Fund LP | 224.07K | 11.00% |
| 2020-11-09 | Logos Global Management LP | 224.07K | 11.00% |
| 2020-11-09 | Arsani William | 224.07K | 11.00% |
| 2020-08-18 | OrbiMed Israel GP Ltd. | 3.18M | 16.40% |
| 2020-08-18 | OrbiMed Israel BioFund GP Limited Partnership | 3.18M | 16.40% |
| 2019-07-26 | 683 Capital Management, LLC | 1.19M | 8.80% |
| 2019-07-26 | 683 Capital Partners, LP | 1.19M | 8.80% |
| 2019-07-26 | Ari Zweiman | 1.19M | 8.80% |
| 2019-07-26 | 683 Capital Partners, LP | 1.19M | 8.80% |
| 2019-07-26 | 683 Capital Management, LLC | 1.19M | 8.80% |
| 2019-07-26 | Ari Zweiman | 1.19M | 8.80% |
| 2019-06-05 | Armistice Capital Master Fund Ltd. | 657.65K | 4.99% |
| 2019-06-05 | Steven Boyd | 657.65K | 4.99% |
| 2019-06-05 | Armistice Capital, LLC | 657.65K | 4.99% |
| 2019-06-05 | Armistice Capital, LLC | 657.65K | 4.99% |
| 2019-06-05 | Armistice Capital Master Fund Ltd. | 657.65K | 4.99% |
| 2019-06-05 | Steven Boyd | 657.65K | 4.99% |
| 2019-05-10 | Biotechnology Value Trading Fund OS LP | 59006.0 | 1.00% |
| 2019-05-10 | BVF Inc. | 1.34M | 9.99% |
| 2019-05-10 | Mark N. Lampert | 1.34M | 9.99% |
| 2019-05-10 | Biotechnology Value Fund, L.P. | 808.13K | 6.10% |
| 2019-05-10 | Biotechnology Value Fund, L.P. | 808.13K | 6.10% |
| 2019-05-10 | BVF Partners OS Ltd. | 59006.0 | 1.00% |
| 2019-05-10 | Biotechnology Value Trading Fund OS LP | 59006.0 | 1.00% |
| 2019-05-10 | BVF Inc. | 1.34M | 9.99% |
| 2019-05-10 | Mark N. Lampert | 1.34M | 9.99% |
| 2019-05-10 | BVF Partners L.P. | 1.34M | 9.99% |
| 2019-05-10 | Biotechnology Value Fund II, L.P. | 439.71K | 3.40% |
| 2019-05-10 | BVF Partners OS Ltd. | 59006.0 | 1.00% |
| 2019-05-10 | Biotechnology Value Fund II, L.P. | 439.71K | 3.40% |
| 2019-05-10 | BVF Partners L.P. | 1.34M | 9.99% |
| 2018-03-13 | Andrew I. McDonald | 1.15M | 12.24% |
| 2018-03-13 | LifeSci Index Partners, LLC | 1.07M | 11.33% |
| 2018-03-13 | LifeSci Venture Partners I, LP | 499.1K | 5.31% |
| 2018-03-13 | LifeSci Venture SPV VII, LLC | 566.97K | 6.03% |
| 2017-05-25 | of 12 Pages | 5.37M | 7.70% |
| 2017-05-25 | of 12 Pages | 7.87M | 11.30% |
| 2017-05-25 | of 12 Pages | 7.87M | 11.30% |
| 2017-05-25 | of 12 Pages | 2.51M | 3.60% |
| 2017-05-25 | of 12 Pages | 2.51M | 3.60% |
| 2017-05-25 | of 12 Pages | 7.87M | 11.30% |
| 2017-05-25 | of 12 Pages | 7.87M | 11.30% |
| 2017-05-25 | of 12 Pages | 5.37M | 7.70% |
| 2017-05-25 | of 12 Pages | 7.87M | 11.30% |
| 2017-05-25 | of 12 Pages | 7.87M | 11.30% |
| 2017-05-22 | Page 2 of 6 Pages | 6.18M | 8.90% |
| 2017-05-19 | OrbiMed Israel GP Ltd. | 2.54M | 36.20% |
| 2017-05-19 | OrbiMed Israel BioFund GP Limited Partnership | 2.54M | 36.20% |
| 2016-02-10 | Novo A/S | 470.95K | 2.10% |
| 2015-02-12 | 2 | 1.77M | 7.90% |
| 2015-02-12 | 2 | 1.77M | 7.90% |
| 2014-10-22 | 1,149,706 | 1.15M | 5.10% |
| 2014-10-22 | 1,149,706 | 1.15M | 5.10% |
ELDN Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2025-12-31 | $1.51 | 81.84M | $123.57M | $22.81M | $641K | $101.41M |
| 2024-12-31 | $4.12 | 48.54M | $200M | $20.55M | $954K | $180.4M |
| 2023-12-31 | $1.80 | 24.62M | $44.31M | $4.61M | $383K | $40.09M |
| 2022-12-31 | $2.28 | 14.29M | $32.57M | $56.41M | $746K | -$23.09M |
| 2021-12-31 | $4.41 | 14.82M | $65.35M | $84.83M | $769K | -$18.71M |
| 2020-12-31 | $15.40 | 15.16M | $233.47M | $114.2M | $144K | $119.42M |
| 2019-12-31 | $10.44 | 655.52K | $6.84M | $8.79M | $324K | -$1.62M |
| 2018-12-31 | $28.80 | 500.3K | $14.41M | $12.97M | -$ | $1.44M |
| 2017-12-31 | $73.08 | 259.87K | $18.99M | $17.23M | -$ | $1.76M |
| 2016-12-31 | $158.44 | 2362 | $374.24K | $23.22M | $3.45M | -$19.4M |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3.08 | 112.42M | $346.27M | $6.15M | $555K | $340.67M |
| 2025-12-31 | $1.51 | 75.43M | $113.9M | $22.81M | $641K | $91.73M |
| 2025-09-30 | $2.59 | 77.16M | $199.83M | $3.67M | $722K | $196.89M |
| 2025-06-30 | $2.71 | 77.16M | $209.09M | $5.74M | $803K | $204.15M |
| 2025-03-31 | $3.39 | 77.13M | $261.46M | $8.5M | $880K | $253.84M |
| 2024-12-31 | $4.12 | 59.79M | $246.33M | $20.55M | $954K | $226.74M |
| 2024-09-30 | $2.49 | 51.95M | $129.35M | $6.75M | $501K | $123.1M |
| 2024-06-30 | $2.51 | 42.28M | $106.12M | $26.04M | $655K | $80.73M |
| 2024-03-31 | $1.99 | 29.99M | $59.68M | $5.66M | $284K | $54.31M |
| 2023-12-31 | $1.80 | 24.21M | $43.58M | $4.61M | $383K | $39.35M |
| 2023-09-30 | $1.37 | 29.97M | $41.06M | $3.67M | $479K | $37.88M |
| 2023-06-30 | $1.37 | 24.01M | $32.89M | $40.95M | $574K | -$7.48M |